Indiana University Health North Hospital is the only hospital in the state of Indiana to offer the new, FDA-approved LINX Reflux Management System, a treatment for Gastroesophageal Reflux Disease. Offered through the Esophageal & Gastric Surgery Center at IU Health North Hospital, the new treatment can provide relief for the millions who suffer from GERD.
Following treatment with the LINX System, the majority of patients substantially reduced or resolved their reflux symptoms, and eliminated use of their reflux medications. Severe regurgitation was eliminated in all patients, and nearly all patients reported a significant decrease in the need for medication. More than nine in 10 patients reported satisfaction with their overall condition after having the LINX System.
A study published this week in the New England Journal of Medicine provides clinical evidence of the safety and effectiveness for Torax Medical’s LINX Reflux Management System, a new, FDA-approved medical device. Numerous studies have shown that reflux symptoms persist in up to 40 percent of patients who receive acid suppression medications and that these symptoms have a negative impact on quality of life and healthcare utilization. The LINX System allows surgeons to leave the stomach intact and support the weak sphincter with a small device placed around the sphincter. The device uses magnetic attraction to help prevent the sphincter from opening to reflux.
“We are very excited to offer innovative solutions for treatment of a very common disease,” stated Daniel McKenna, MD, Medical Director of the Esophageal & Gastric Surgery Center at IU Health North Hospital. “This is a much needed advancement for a disease that can be very debilitating. While medication can assist with alleviating symptoms of GERD, this medical device provides a solution to treat the underlying problem.”
For more information, you can visit iuhealth.org/gerdlinx.